CTBO (Cantabio Pharmaceuticals) Total Operating Expense: $1.33 Mil (TTM As of Dec. 2018)


What is Cantabio Pharmaceuticals Total Operating Expense?

Cantabio Pharmaceuticals CTBO Total Operating Expense is $1.33 Mil as of Dec. 2018.

Cantabio Pharmaceuticals's Total Operating Expense for the three months ended in Dec. 2018 was $0.24 Mil. Cantabio Pharmaceuticals's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2018 was $1.33 Mil.

Cantabio Pharmaceuticals Total Operating Expense Related Terms

Cantabio Pharmaceuticals Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Cantabio Pharmaceuticals's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantabio Pharmaceuticals Total Operating Expense Chart

Cantabio Pharmaceuticals Annual Data
Trend Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18
Total Operating Expense
Get a 7-Day Free Trial 0.09 0.03 0.84 1.07 1.35

Cantabio Pharmaceuticals Quarterly Data
Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 0.62 0.24 0.23 0.24

Cantabio Pharmaceuticals Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.33 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $1.33 Mil mean?
Cantabio Pharmaceuticals (CTBO) has a Total Operating Expense of $1.33 Mil as of Dec. 2018. Total operating expense is the primary recurring expense associated with central operations. View historical data on Cantabio Pharmaceuticals and its competitors.
Is Cantabio Pharmaceuticals' Total Operating Expense too high?
Cantabio Pharmaceuticals' current Total Operating Expense is $1.33 Mil.
How does Cantabio Pharmaceuticals' Total Operating Expense compare to TNTY and ETNI?
Cantabio Pharmaceuticals' Total Operating Expense of $1.33 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Cantabio Pharmaceuticals and its competitors. Cantabio Pharmaceuticals's current Total Operating Expense is $1.33 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantabio Pharmaceuticals stock overvalued right now?
Cantabio Pharmaceuticals (CTBO) has a current Total Operating Expense of $1.33 Mil. The current Total Operating Expense is $1.33 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Cantabio Pharmaceuticals (CTBO), the current Total Operating Expense is $1.33 Mil as of Dec. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantabio Pharmaceuticals Business Description

Address 1250 Oakmead Parkway, Sunnyvale, CA, USA, 94085
Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson's disease and Alzheimer's disease and other related diseases. In addition, In addition, it is also engaged in the development of therapeutic proteins that can pass through the blood-brain barrier and supplement in vivo levels of proteins which display loss of function during disease conditions.